Skip to main content
logo
Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.860
+0.080 (4.49%)
At close: Sep 4, 2026, 4:00 PM EDT
1.910
+0.050 (2.69%)
After-hours: Sep 4, 2026, 7:59 PM EDT

Skye Bioscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-50.49-55.92-26.57-37.64-19.48-8.52
Depreciation & Amortization
0.690.720.30.120.110.03
Other Amortization
--0.60.330.490.59
Loss (Gain) From Sale of Assets
0.15-0.36-1.350.3--
Asset Writedown & Restructuring Costs
---21.22--
Stock-Based Compensation
6.37.778.320.990.630.87
Other Operating Activities
3.25--3.911.26.27-0.1
Change in Accounts Payable
1.061.4-0.59-0.70.80.52
Change in Other Net Operating Assets
0.243.34-2.040.23-1.560.13
Operating Cash Flow
-38.81-43.06-25.24-13.95-12.74-6.47
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
--0.01-1.6-0.01-0.09-0.09
Sale of Property, Plant & Equipment
0.450.361.365.53--
Cash Acquisitions
---1.085.31-
Investment in Securities
22.75-19.85----
Investing Cash Flow
23.2-19.5-0.256.65.21-0.09

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---4.97--
Long-Term Debt Issued
----0.68-
Total Debt Issued
---4.970.68-
Long-Term Debt Repaid
----0.26-0.89-
Net Debt Issued (Repaid)
-0.18--4.71-0.21-
Issuance of Common Stock
--9012014.01
Other Financing Activities
0.020.03-6.43-0.27--0.94
Financing Cash Flow
-0.160.0383.5616.44-0.2113.08

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-15.77-62.5358.089.09-7.746.51

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-38.81-43.07-26.84-13.96-12.84-6.57
Free Cash Flow Growth
------
Free Cash Flow Per Share
-7.83-8.69-5.88-15.95-46.24-32.30
Levered Free Cash Flow
-18.71-22.95-12.94-11.13-9.44-3.28
Unlevered Free Cash Flow
-18.71-22.95-13.07-10.89-9.51-3.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.01-0.430.20.330.04
Cash Income Tax Paid
00.010.0100.010
Change in Working Capital
1.294.73-2.63-0.47-0.760.65
SEC Filings: 10-K · 10-Q